Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brett Kaplan currently holds 77,500 shares of Eliem Therapeutics, Inc. (ELYM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brett Kaplan has been a net neutral trader of ELYM stock. They have purchased $0 and sold $0 worth of shares.
Brett Kaplan's most recent insider trade was on Aug 26, 2024, when they sold 77,500 shares at $0.00 per share.
Brett Kaplan serves as Executive at Eliem Therapeutics, Inc. (ELYM). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Brett Kaplan holds the position of Executive at Eliem Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Brett Kaplan has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Brett Kaplan was on Aug 26, 2024, when they purchased $0 worth of ELYM shares. This transaction involved 77,500 shares at N/A per share.
Brett Kaplan currently owns 77,500 shares of Eliem Therapeutics, Inc. (ELYM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brett Kaplan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brett Kaplan has 2 Form 4 filings on record as an insider at Eliem Therapeutics, Inc..
Set alerts for Brett Kaplan and 40,000+ other insiders.